448 related articles for article (PubMed ID: 21570475)
1. Particulate vaccines: on the quest for optimal delivery and immune response.
De Temmerman ML; Rejman J; Demeester J; Irvine DJ; Gander B; De Smedt SC
Drug Discov Today; 2011 Jul; 16(13-14):569-82. PubMed ID: 21570475
[TBL] [Abstract][Full Text] [Related]
2. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
[TBL] [Abstract][Full Text] [Related]
3. Immunity in response to particulate antigen-delivery systems.
Storni T; Kündig TM; Senti G; Johansen P
Adv Drug Deliv Rev; 2005 Jan; 57(3):333-55. PubMed ID: 15560945
[TBL] [Abstract][Full Text] [Related]
4. Particulate delivery systems for vaccines: what can we expect?
Bramwell VW; Perrie Y
J Pharm Pharmacol; 2006 Jun; 58(6):717-28. PubMed ID: 16734973
[TBL] [Abstract][Full Text] [Related]
5. PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity.
Silva AL; Soema PC; Slütter B; Ossendorp F; Jiskoot W
Hum Vaccin Immunother; 2016 Apr; 12(4):1056-69. PubMed ID: 26752261
[TBL] [Abstract][Full Text] [Related]
6. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
De Magistris MT
Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles and microparticles as vaccine-delivery systems.
Singh M; Chakrapani A; O'Hagan D
Expert Rev Vaccines; 2007 Oct; 6(5):797-808. PubMed ID: 17931159
[TBL] [Abstract][Full Text] [Related]
8. Targeting nanoparticles to dendritic cells for immunotherapy.
Cruz LJ; Tacken PJ; Rueda F; Domingo JC; Albericio F; Figdor CG
Methods Enzymol; 2012; 509():143-63. PubMed ID: 22568905
[TBL] [Abstract][Full Text] [Related]
9. Subunit-based mucosal vaccine delivery systems for pulmonary delivery - Are they feasible?
Marasini N; Kaminskas LM
Drug Dev Ind Pharm; 2019 Jun; 45(6):882-894. PubMed ID: 30767591
[TBL] [Abstract][Full Text] [Related]
10. Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors.
Walcher P; Mayr UB; Azimpour-Tabrizi C; Eko FO; Jechlinger W; Mayrhofer P; Alefantis T; Mujer CV; DelVecchio VG; Lubitz W
Expert Rev Vaccines; 2004 Dec; 3(6):681-91. PubMed ID: 15606353
[TBL] [Abstract][Full Text] [Related]
11. Fully mobilizing host defense: building better vaccines.
Raychaudhuri S; Rock KL
Nat Biotechnol; 1998 Nov; 16(11):1025-31. PubMed ID: 9831030
[TBL] [Abstract][Full Text] [Related]
12. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
Gupta RK; Chang AC; Siber GR
Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260
[TBL] [Abstract][Full Text] [Related]
14. Bioadhesive delivery systems for mucosal vaccine delivery.
Baudner BC; O'Hagan DT
J Drug Target; 2010 Dec; 18(10):752-70. PubMed ID: 21039314
[TBL] [Abstract][Full Text] [Related]
15. Synthetic vehicles for DNA vaccination.
van den Berg JH; Nuijen B; Schumacher TN; Haanen JB; Storm G; Beijnen JH; Hennink WE
J Drug Target; 2010 Jan; 18(1):1-14. PubMed ID: 19814658
[TBL] [Abstract][Full Text] [Related]
16. Micro/nanoparticle adjuvants for antileishmanial vaccines: present and future trends.
Badiee A; Heravi Shargh V; Khamesipour A; Jaafari MR
Vaccine; 2013 Jan; 31(5):735-49. PubMed ID: 23219436
[TBL] [Abstract][Full Text] [Related]
17. Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery.
Mody KT; Popat A; Mahony D; Cavallaro AS; Yu C; Mitter N
Nanoscale; 2013 Jun; 5(12):5167-79. PubMed ID: 23657437
[TBL] [Abstract][Full Text] [Related]
18. Enhancing the therapeutic efficacy of CpG oligonucleotides using biodegradable microparticles.
Malyala P; O'Hagan DT; Singh M
Adv Drug Deliv Rev; 2009 Mar; 61(3):218-25. PubMed ID: 19168103
[TBL] [Abstract][Full Text] [Related]
19. Liposomal vaccine delivery systems.
Henriksen-Lacey M; Korsholm KS; Andersen P; Perrie Y; Christensen D
Expert Opin Drug Deliv; 2011 Apr; 8(4):505-19. PubMed ID: 21413904
[TBL] [Abstract][Full Text] [Related]
20. Particle-based vaccines for transcutaneous vaccination.
Combadière B; Mahé B
Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):293-315. PubMed ID: 17915323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
